Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21291-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- B3GNT6 antibody
- Antibody type
- Polyclonal
- Description
- B3GNT6 antibody (Cat. #21291-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Ellagic acid alleviates TNBS-induced intestinal barrier dysfunction by regulating mucin secretion and maintaining tight junction integrity in rats.
IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
G-quadruplex-enhanced circular single-stranded DNA (G4-CSSD) adsorption of miRNA to inhibit colon cancer progression.
An etanercept O-glycovariant with enhanced potency.
Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Peng B, Xue L, Yu Q, Zhong T
International journal of food sciences and nutrition 2023;74(4):476-486
International journal of food sciences and nutrition 2023;74(4):476-486
IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
Cao P, Wu Y, Sun D, Zhang W, Qiu J, Tang Z, Xue X, Qin L
Cancer medicine 2023 Feb;12(4):4405-4420
Cancer medicine 2023 Feb;12(4):4405-4420
G-quadruplex-enhanced circular single-stranded DNA (G4-CSSD) adsorption of miRNA to inhibit colon cancer progression.
Wu H, Zhong W, Zhang R, Ding Y, Qu C, Lai K, Pang Z, Yin S, Zhang G, Chen S
Cancer medicine 2023 Apr;12(8):9774-9787
Cancer medicine 2023 Apr;12(8):9774-9787
An etanercept O-glycovariant with enhanced potency.
Biel TG, Faison T, Matthews AM, Zou G, Ortega-Rodriguez U, Pegues MA, Azer N, Gomez F, Johnson S, Rogstad S, Chen K, Xie H, Agarabi C, Rao VA, Ju T
Molecular therapy. Methods & clinical development 2022 Jun 9;25:124-135
Molecular therapy. Methods & clinical development 2022 Jun 9;25:124-135
Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Ye J, Wei X, Shang Y, Pan Q, Yang M, Tian Y, He Y, Peng Z, Chen L, Chen W, Wang R
Oncogene 2017 Nov 16;36(46):6391-6407
Oncogene 2017 Nov 16;36(46):6391-6407
No comments: Submit comment
No validations: Submit validation data